Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Hemodynamic profile of new K+ channel activator

Jan. 21, 1998

CVT-313: promising antiproliferative agent that inhibits CDK2

Jan. 20, 1998

SmithKline Beecham develops Lp-PLA2 inhibitors for atherosclerosis

Jan. 20, 1998

CV Therapeutics seeks permission to move CVT-510 to clinical trials

Jan. 20, 1998

Cardizem Monovial now available in U.S.

Jan. 19, 1998

Novartis reveals agents for atherosclerosis and chronic inflammation

Jan. 19, 1998

Inhibition of monocyte-endothelial cell adhesion in atherogenesis by anti-CD43 MAb

Jan. 16, 1998

BASF reports new endothelin antagonists

Jan. 16, 1998

Compounds for cardiovascular diseases described by BMS

Jan. 16, 1998

Phase III trials of Natrecor BNP now successfully completed

Jan. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...